88 related articles for article (PubMed ID: 28868995)
1. Central line-associated bloodstream infections in Australian ICUs: evaluating modifiable and non-modifiable risks in Victorian healthcare facilities.
Spelman T; Pilcher DV; Cheng AC; Bull AL; Richards MJ; Worth LJ
Epidemiol Infect; 2017 Oct; 145(14):3047-3055. PubMed ID: 28868995
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?
Rock C; Thom KA; Harris AD; Li S; Morgan D; Milstone AM; Caffo B; Joshi M; Leekha S
Infect Control Hosp Epidemiol; 2016 Feb; 37(2):143-8. PubMed ID: 26493213
[TBL] [Abstract][Full Text] [Related]
3. The incidence, aetiology and antimicrobial susceptibility of central line-associated bloodstream infections in intensive care unit patients at a private tertiary care hospital in Mumbai, India.
Singhal T; Shah S; Thakkar P; Naik R
Indian J Med Microbiol; 2019; 37(4):521-526. PubMed ID: 32436874
[TBL] [Abstract][Full Text] [Related]
4. A survey of preventive measures used and their impact on central line-associated bloodstream infections (CLABSI) in intensive care units (SPIN-BACC).
Gonzales M; Rocher I; Fortin E; Fontela P; Kaouache M; Tremblay C; Frenette C; Quach C
BMC Infect Dis; 2013 Dec; 13():562. PubMed ID: 24289473
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of catheter-associated bloodstream infections: development and validation of a fully automated algorithm.
Catho G; Fortchantre L; Teixeira D; Galas-Haddad M; Boroli F; Chraïti MN; Abbas M; Harbarth S; Buetti N;
Antimicrob Resist Infect Control; 2024 Apr; 13(1):38. PubMed ID: 38600526
[TBL] [Abstract][Full Text] [Related]
6. Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019.
Ben-David D; Vaturi A; Wulffhart L; Temkin E; Solter E; Carmeli Y; Schwaber MJ; ;
Euro Surveill; 2023 Jun; 28(25):. PubMed ID: 37347415
[TBL] [Abstract][Full Text] [Related]
7. Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.
Liu H; Herzig CTA; Dick AW; Furuya EY; Larson E; Reagan J; Pogorzelska-Maziarz M; Stone PW
Health Serv Res; 2017 Jun; 52(3):1079-1098. PubMed ID: 27451968
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.
Gandra S; Singh SK; Chakravarthy M; Moni M; Dhekane P; Mohamed Z; Shameen F; Vasudevan AK; Senthil P; Saravanan T; George A; Sinclair D; Stwalley D; van Rheenen J; Westercamp M; Smith RM; Leekha S; Warren DK
Infect Control Hosp Epidemiol; 2024 Feb; 45(2):157-166. PubMed ID: 37593953
[TBL] [Abstract][Full Text] [Related]
9. Etiology and utility of hospital-onset bacteremia as a safety metric for targeted harm reduction.
Stack MA; Dbeibo L; Fadel W; Kelley K; Sadowski J; Beeler C
Am J Infect Control; 2024 Feb; 52(2):195-199. PubMed ID: 37295676
[TBL] [Abstract][Full Text] [Related]
10. A Two-Year Surveillance of Central Line-Associated Bloodstream Infections in the Trauma ICU of a Tertiary Care Hospital in India.
Maqbool S; Sharma R
Cureus; 2023 Sep; 15(9):e45325. PubMed ID: 37849567
[TBL] [Abstract][Full Text] [Related]
11. Decreasing central line-associated bloodstream infections rates in intensive care units in 30 low- and middle-income countries: An INICC approach.
Rosenthal VD; Jin Z; Brown EC; Dongol R; De Moros DA; Alarcon-Rua J; Perez V; Stagnaro JP; Alkhawaja S; Jimenez-Alvarez LF; Cano-Medina YA; Valderrama-Beltran SL; Henao-Rodas CM; Zuniga-Chavarria MA; El-Kholy A; Agha H; Sahu S; Mishra SB; Bhattacharyya M; Kharbanda M; Poojary A; Nair PK; Myatra SN; Chawla R; Sandhu K; Mehta Y; Rajhans P; Abdellatif-Daboor M; Chian-Wern T; Gan CS; Mohd-Basri MN; Aguirre-Avalos G; Hernandez-Chena BE; Sassoe-Gonzalez A; Villegas-Mota I; Aleman-Bocanegra MC; Bat-Erdene I; Carreazo NY; Castaneda-Sabogal A; Janc J; Hlinkova S; Yildizdas D; Havan M; Koker A; Sungurtekin H; Dinleyici EC; Guclu E; Tao L; Memish ZA; Yin R
Am J Infect Control; 2024 May; 52(5):580-587. PubMed ID: 38154739
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Central Line-Associated Bloodstream Infections Through Educational Interventions in Adult Intensive Care Units: A Systematic Review.
Foka M; Nicolaou E; Kyprianou T; Palazis L; Kyranou M; Papathanassoglou E; Lambrinou E
Cureus; 2021 Aug; 13(8):e17293. PubMed ID: 34552831
[TBL] [Abstract][Full Text] [Related]
13. Hospital-acquired bloodstream infections in patients with cancer: current knowledge and future directions.
MacPhail A; Dendle C; Slavin M; McQuilten Z
J Hosp Infect; 2024 Jun; 148():39-50. PubMed ID: 38490489
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the outcome of a bundle with 11 components and the INICC multidimensional approach in decreasing rates of central line-associated bloodstream infections across nine Asian countries.
Rosenthal VD; Yin R; Myatra SN; Divatia JV; Biswas SK; Shrivastava AM; Perez V; Wang QY; Todi SK; Tang SF; Tai CW; Lee PC; Sengupta D; Sarma S; Sandhu K; Rodrigues C; Nag B; Mohd-Basri MN; Mehta Y; Kharbanda M; Kansal S; Jain AC; Davaadagva N; Chuah SL; Low MSY; Gan CS; Bt Madzlan Kushairi M; Bhattacharyya M; Bhakta A; Begzjav T; Bat-Erdene B; Bali RK; Badyal B; Arora A; Arjun R; Tao L; Jin Z; Chawla R
J Vasc Access; 2024 Mar; ():11297298241242163. PubMed ID: 38539085
[TBL] [Abstract][Full Text] [Related]
15. Comparative epidemiology of hospital-onset bloodstream infections (HOBSIs) and central line-associated bloodstream infections (CLABSIs) across a three-hospital health system.
Krishnan J; Gettler EB; Campbell M; Kalu IC; Seidelman J; Smith B; Lewis S
Infect Control Hosp Epidemiol; 2024 Mar; ():1-7. PubMed ID: 38505940
[TBL] [Abstract][Full Text] [Related]
16. Pilot validation of central line-associated bloodstream infection data in a voluntary surveillance system in Taiwan between October and December 2021.
Wu HH; Chang SL; Su CH; Tseng SH; Chien LJ
Infect Prev Pract; 2024 Mar; 6(1):100326. PubMed ID: 38077243
[TBL] [Abstract][Full Text] [Related]
17. Patient-level costs of central line-associated bloodstream infections caused by multidrug-resistant microorganisms in a public intensive care unit in Brazil: a retrospective cohort study.
Nassar Júnior AP; Bezerra IL; Malheiro DT; Diaz MDM; Schettino GPP; Pereira AJ
Rev Bras Ter Intensiva; 2022; 34(4):529-533. PubMed ID: 36888835
[No Abstract] [Full Text] [Related]
18. Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic review.
Satta G; Rawson TM; Moore LSP
Infect Prev Pract; 2023 Dec; 5(4):100313. PubMed ID: 37920796
[TBL] [Abstract][Full Text] [Related]
19. Controlling the chaos: Information management in home-infusion central-line-associated bloodstream infection (CLABSI) surveillance.
Hannum SM; Oladapo-Shittu O; Salinas AB; Weems K; Marsteller J; Gurses AP; Shpitser I; Klein E; Cosgrove SE; Keller SC
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e69. PubMed ID: 37113198
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
